icom_donate

Donate Today

icon_get_involved

Get Involved

icon_friend

Friends of

Tobias’ story

Tobias was diagnosed at just eight weeks old with Infantile Fibrosarcoma – a tumour so rare that only 50 children in the last 20 years in Europe have been diagnosed with it. His mum, Katherine, shares Tobias’ story.

Tobias was born on 28th September 2016. He was 7lb 6oz and a bouncing, beautiful, healthy baby boy … or so we thought.

In the first week after Tobias’ birth he put on a pound of weight. We were over the moon. I was breastfeeding trying to do my best for him and had been worried about it as friends had told it was tricky. I thought I’d really cracked it!

A few weeks later when the health visitor came back, he hadn’t put on any further weight. I was in shock and full of hormones and cried and cried as I felt I’d let him down. I went to lactation consultants and breastfeeding groups but to no avail – still no weight gain. Everyone told me not to worry – it was a feeding issue; a tongue tie etc.

By this time he was coming up to his eight week check. He had almost stopped feeding and in desperation we had tried bottle feeding but he refused the bottle as well. The GP took one look at him and said he was rather skinny. He didn’t want to hold his head up or track something in her hand. She mentioned a lump that she thought might be a hard poo as he was slim. I put it to the back of my mind.

That night we took him to A&E as he had dry nappies and was barely feeding at all. I mentioned the lump and they said it wasn’t there and sent him back home after determining that he could wee.

The lactation consultant recommended bottle feeding but he refused all bottles so we went back to the GP. She said she had been thinking about him all day and wanted us to go back to A&E regarding the lump.

We were told he had cancer

Tobias storyWe got there and waited. People came to feel the lump. He had blood tests, a cannula – we were there all night. He was then sent for an ultrasound. I saw the mass and knew it was bad news. We were admitted to the ward and he was put on fluids. By this point he was asleep all the time. The next morning we were told he had cancer and we were transferred to Ward 84 – children’s oncology at The Royal Manchester Children’s Hospital.

What happened next is a blur of tears. Tobias had a nasogastric (NG) tube placed. He was so tiny that they struggled to get blood out of him and he was covered in bruises.

We took turns to hold him while he slept as the lump protruded out of his side and back. We thought he was going to die as the lump seemed to be growing by the second.

He was diagnosed with a mesoblastic nephroma – a very rare type of kidney tumour. However, we were told it would be treatable by removing the kidney and the tumour together.

The surgery was not as straight forward as hoped. The tumour was around the kidney with a difficult blood and nerve supply. We were told he may not be able to move his right leg again and he had lost his body weight in blood and was in ICU.

After we were sent home, we were told that the biopsy revealed infantile fibrosarcoma – the same type of tumour but usually in limbs. Later that day we were then told that Tobias had a tumour on his spine that had been missed and would need chemotherapy.

The start of chemoTreatment for Tobias

His chemo was meant to be weekly as an outpatient but he had so many temperatures and illnesses that we were barely out of hospital. During his second round of chemotherapy he suddenly became worse. Another ultrasound and CT scan revealed a new tumour near his liver. He would need another surgery and stronger chemo which would make him extremely ill. We were devastated.

His surgery was a success but the chemo they chose for Tobias is extremely toxic. It’s rare to use it on such a young baby. It can cause damage to the heart, along with hallucinations, sickness, seizures – the list is endless.

Before his first round I asked the consultant what his options would be if he were to grow new tumours during this chemo. I was told only radical surgery, organ removal or radiotherapy and these things would only be palliative for Tobias. There is a trial drug using immunotherapy being used in other countries but this unfortunately isn’t funded by the NHS.

Thankfully Tobias has responded well to the chemo and is now in remission. He still doesn’t eat and is fully tube fed and doesn’t speak much either.

High chance of relapse

The chance of Tobias relapsing is extremely high and so we continue to raise funds for the trial treatment should this ever need to become an option. Costs could extend into hundreds of thousands of pounds.

I have to try to give Tobias a chance should the worst happen. Should we no longer need the funds, they will be donate to charities that research children’s cancer.

Tobias has lived with cancer all his life. He never stops smiling and everyone who meets him, loves him. We have to live with the thought that we may lose him every day.

If you would like to donate to help fund lifesaving treatment for Tobias, just visit the family’s fundraising page.

Nancy Dykes

Nancy Dykes

Nancy, 11, was diagnosed with rhabdomyosarcoma when she was just 2 years old. She was treated with Proton Beam Therapy (PBT) in Germany but unfortunately relapsed less than a year later. The family were then sent to Germany for a second round of PBT. Although treatment helped to cure Nancy’s cancer, she has been left with lots of lasting effects which will require ongoing treatment throughout her life. Here Nancy and her mum, Antonia, share their story in the hope it will help others, raise awareness, and raise more money for children’s cancer research.

Prof John Hickman

Prof John Hickman

Why I am a Trustee of CCRF
 
I am a relative of the Larkin family and knew Rosie Larkin ( Friends of Rosie, now CCRF) when she had and then died of neuroblastoma, aged six. At that time, I was a scientist and professor at Manchester University, actively working on the problem of why some cancers do not die despite intensive and toxic therapies.  Seeing Rosie during her unsuccessful therapy and then attending her funeral, besides being emotional, drove me to double down on my own research as well as to support the Charity as best I could as a cancer researcher. I spent over a decade as the Chairman of the Scientific Advisory Board of the CCRF, when the Board moulded policies to ensure that funds raised for research into childhood cancers were distributed only to clinicians and researchers who had the brightest ideas that could impact of cancer medicine for children.
 
My role on the Board
 
As a Trustee,  I hope that my many decades of experience in cancer research and medicine can help the CCRF determine where best the funds that are raised can be invested in cutting edge research and medicine. I am also keen that the CCRF brings together UK and international experts in science and cancer medicine to brainstorm on how best to advance the treatment of childhood cancers.
 
My Background
 
I was a Professor of Pharmacology at Manchester University, working on drug resistance in cancer. I then moved to Paris, where I still live, to head cancer drug discovery at a French pharmaceutical company (Servier). I then headed an EU consortium for six years that brought together researchers from the pharmaceutical industry, universities and biotechnology companies, from all over Europe and the UK, to improve cancer drug discovery. I continue to be active in cancer health policy, publishing in the medical literature.
Katrina

Katrina London

Why I am a Trustee of CCRF

I have spent my professional career representing individuals and families affected by the devastating asbestos-related cancer, mesothelioma, which has no cure and for which there are only a limited number of palliative treatments available on the NHS.

I joined CCRF because I wanted to bring my understanding of the need to raise awareness of less well known cancers and passion for the need to secure improved funding for research to children facing a cancer diagnosis.

My role on the Board

I am responsible for oversight of our collaboration agreements with other charities to co-fund research into cures and treatments for childhood cancers. I also manage our challenge events and help with community fundraising. 

My Background

I am a Senior Associate at Irwin Mitchell LLP and specialise in Asbestos Disease Litigation, acting on behalf of victims of asbestos related diseases and their families.  Over the years, I have undertaken a number of fundraising challenges to raise money for cancer research, including a 1000 mile cycle ride from Glasgow to Southampton.   

Carla

Carla Nuttall

Why I’m a Trustee of CCRF
 
I became a trustee of the Children’s Cancer Research Fund because I believe every child deserves the chance to grow up healthy and with everything to look forward to in life. Like many people, I’ve seen the impact cancer can have on families and I wanted to do something that could make a real difference. This started through my work as an ambassador for Cyclists Fighting Cancer, which supported young people and their families in finding strength, confidence, and joy through movement.
 
That experience shaped my understanding of the challenges families face and the importance of community-led support – but crucially, the clear need for that to go hand-in-hand with targeted research and long-term solutions.
 
This is why I’m so passionate about the work CCRF does and proud to contribute to a cause that gives children and their families, the greatest chance of living a life without limits.
 
My Role on the Board
 
I support CCRF’s mission by bringing my experience in brand, marketing, and communications to the board. My focus is on helping CCRF tell its story in a way that resonates with people – whether that’s families, researchers, donors, or the wider public. I work alongside an incredible team to strengthen CCRF’s voice, build trust, and grow awareness so that more children and families can benefit from the breakthroughs we’re helping to fund.
 
My Background
 
I’m the Executive Director of Corporate Affairs and Marketing for The Growth Company, a social enterprise dedicated to helping people, businesses, and places to thrive through its market-leading insight, employment, skills and business support.
My passion is to help the organisations I work with to communicate with clarity, purpose, and integrity. That’s why I’ve spent my career in strategic communications supporting organisations that want to make a positive difference – CCRF could not fit my sense of purpose any better.